Abstract Library

#1149 Optimal Clinical Effect of Sandostatin LAR Treatment for Gastroenteropancreatic (GEP) Carcinoid

Introduction: The incidence of carcinoid is 2/100 000 with a consistent trend grow due to improved diagnosis of these tumors in recent years. There are two peaks of carcinoid incidence – the first between the 15th and 25th years and the second–between the 65th and 75th years

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Robev B, Sergieva S,

Keywords: Carcinoid, Sandostatin LAR,

#1141 New Hybrid SPECT-CT Modality for Imaging Purposes in Patients with Medullary Thyroid Cancer (MTC)

Introduction: Loco-regional lymph node and distant metastases are found very often in patients with MTC of less than 1 cm. There is not good MTC response to systemic chemotherapy or to external been radiotherapy. Radical thyroidectomy is the main method of therapy. Early diagnosis and correct N/M-staging are extremely important for the management of MTC. New hybrid SPECT-CT γ-cameras allow the fusion of anatomical and functional modalities. SPECT-CT is used in order to optimize somatostatin-receptor scintigraphic protocols.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Sergieva S

Authors: Sergieva S, Pandev R, Robev B, Fakirova A,

Keywords: MTC, somatostatin SPECT-CT image,

#1005 Role of Somatostain-Receptor Scintigraphy with SPECT-CT in Diagnosis, Staging and Follow-Up of Patients with Neuroendocrine Tumors (NETs)

Introduction: SPECT-CT study improves the certainty and accuracy of SPECT images.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Sergieva S

Authors: Sergieva S, Robev B, Mihaylova J, Fakirova A, Krasteva R,

Keywords: SPECT-CT, Tektrotyd,